EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Plant-Derived Bioactive Compounds in Chronic Obstructive Pulmonary Disease: Targeting Oxidative Stress and Inflammatory Signaling

Saurabh Kumar, Osaid Masood, Shama Parveen, Prince Kumar Singh, Monisha Banerjee

Current Issues in Molecular Biology · 12.11.2026 · 48 (11) · 1206

DOI: 10.3390/cimb48111206 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Current Issues in Molecular Biology, online erschienen am 12.11.2026. Verfasst von Saurabh Kumar und 4 weiteren Autor:innen. Die Arbeit nennt 182 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chronic obstructive pulmonary disease (COPD) is characterised by persistent airflow limitation arising from chronic inflammation, oxidative stress, mucus hypersecretion, protease–antiprotease imbalance, airway remodelling, and emphysematous destruction. This review evaluates plant-derived bioactive compounds with reported activity against molecular processes implicated in COPD. Resveratrol, kaempferol, quercetin, fisetin, epigallocatechin gallate, gallic acid, ursolic acid, hesperidin, apigenin, and luteolin are examined with emphasis on Nrf2, NF-κB, MAPKs, PI3K/Akt, SIRT1, TLR4, and NLRP3 signalling. In selected cellular and animal models, these compounds have been reported to reduce oxidative stress, inflammatory mediator release, mucus production, metalloproteinase activity, and tissue injury. However, these experimental findings do not establish therapeutic efficacy in patients with COPD. Some also affect autophagy, corticosteroid sensitivity, and pathways associated with cellular senescence. Overall, the evidence is derived mainly from cultured cells and animal models, with limited clinical data. Poor oral bioavailability, rapid metabolism, uncertain pulmonary exposure, formulation variability, dose standardisation, and potential drug interactions remain major translational limitations. Future studies should define pharmacokinetics, lung tissue exposure, optimal formulations, safety, and interactions with standard COPD therapies, followed by adequately powered clinical trials assessing exacerbations, lung function, symptoms, exercise capacity, quality of life, and treatment-related adverse effects in well-defined COPD populations.

Zitieren

APA

Kumar, S., Masood, O., Parveen, S., Singh, P. K., & Banerjee, M. (2026). Plant-Derived Bioactive Compounds in Chronic Obstructive Pulmonary Disease: Targeting Oxidative Stress and Inflammatory Signaling. Current Issues in Molecular Biology, 48(11), 1206. https://doi.org/10.3390/cimb48111206

Vancouver

Kumar S, Masood O, Parveen S, Singh PK, Banerjee M. Plant-Derived Bioactive Compounds in Chronic Obstructive Pulmonary Disease: Targeting Oxidative Stress and Inflammatory Signaling. Current Issues in Molecular Biology. 2026;48(11):1206. doi:10.3390/cimb48111206

BibTeX
@article{Kumar2026,
  author = {Kumar, Saurabh and Masood, Osaid and Parveen, Shama and Singh, Prince Kumar and Banerjee, Monisha},
  title = {Plant-Derived Bioactive Compounds in Chronic Obstructive Pulmonary Disease: Targeting Oxidative Stress and Inflammatory Signaling},
  journal = {Current Issues in Molecular Biology},
  year = {2026},
  volume = {48},
  number = {11},
  pages = {1206},
  doi = {10.3390/cimb48111206}
}
Kostenlos starten →